Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)

National Institutes of Health (NIH) · NIH Institute/Center · PAR-26-132

Source: Grants.gov · View original posting ↗

AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.

Amount not listed

DeadlineFinal application due date.

Not yet posted

Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).

—

MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).

U01

DurationMaximum project period for a single award.

—

Expected awardsHow many awards the funder anticipates making under this opportunity.

—

Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).

Standard NIH dates

Open dateWhen applications open (or opened).

Mar 4, 2026

Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.

—

Clinical trialWhether proposed projects must, may, or must not include a clinical trial.

Not allowed